Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
CALC
CALC
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CALC News
Adobe and CalciMedica Executives Increase Stock Holdings
Jun 29 2026
NASDAQ.COM
CalciMedica Secures $49 Million Financing to Advance Pulmonary Hypertension Strategy
Jun 24 2026
PRnewswire
FDA Reviews CalciMedica's KOURAGE Trial Protocol Amendment
Jun 24 2026
PRnewswire
CalciMedica Secures $49 Million Financing for Pulmonary Hypertension Strategy
Jun 24 2026
Newsfilter
CalciMedica Receives FDA Review of KOURAGE Trial Progress
Jun 24 2026
Newsfilter
CalciMedica Reports Q1 2026 Financial Results with Significant Income Growth
May 12 2026
seekingalpha
CalciMedica Reports Q1 2026 Financial Results and Clinical Updates
May 12 2026
PRnewswire
CalciMedica Reports FY GAAP EPS of -$1.97
Mar 03 2026
seekingalpha
Wall Street Analysts Adjust Ratings
Jan 29 2026
Benzinga
CalciMedica Discontinues Trial, Stock Faces Volatility
Jan 28 2026
stocktwits
CalciMedica Halts KOURAGE Clinical Trial Amid Safety Concerns
Jan 28 2026
Benzinga
U.S. Stocks Mixed as Energy Shares Rise Amid Crude Inventory Decline
Jan 28 2026
Benzinga
U.S. Stocks Mostly Higher; Starbucks Beats Q1 Sales Expectations
Jan 28 2026
Benzinga
CalciMedica Halts Auxora Clinical Trial Due to Safety Concerns
Jan 28 2026
PRnewswire
CalciMedica (CALC) Anticipates Key Phase 2 Data Readout in 2026 with $14.1M Cash Position
Jan 21 2026
NASDAQ.COM
CalciMedica Reports Third Quarter 2025 Financial Results and Provides Clinical & Corporate Updates
Nov 12 2025
PRnewswire
Show More News
